Deposition of complement proteins on cells treated by photodynamic therapy in vitro

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 189-203

  Cecic, Ivana ^a   Korbelik, Mladen ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Apoptosis; Complement system; Heat shock protein 70; Photodynamic therapy

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; HEAT SHOCK PROTEIN 70; PHOTOFRIN; PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UMBILICAL VEIN;

ANIMALIA;

EID: 33644768293     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.110     Document Type: Article

References (36)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90:889-905.
2. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55:145-157.
3. Korbelik M, Cecic I. Mechanism of tumor destruction by photodynamic therapy. In: Nalwa HS, editor. Handbook of Photochemistry and Photobiology. Stevenson Ranch (CA): American Scientific Publishers, 2003; Vol. 4, 39-77.
4. Cecic I, Parkins CS, Korbelik M. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem Photobiol 2001; 74:712-720.
5. Cecic I, Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett 2002; 183:43-51.
6. Cecic I, Serrano K, Gyongyossy-Issa M, Korbelik M. Characteristics of complement activation in mice bearing Lewis lung carcinoma treated by photodynamic therapy. Cancer Lett 2005; 225:215-223.
7. Cooper NR. Biology of the complement system. In: Galin JI, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlations. Philadelphia: Lippincott Williams & Wilkins 1999; 281-315.
8. Erdei A, Prechl J, Isaák A, Molnár E. Regulation of B-cell activation by complement receptors CD21 and CD35. Curr Pharm Des 2003; 9:1849-1860.
9. Esser AF, Sodetz JM. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement. Methods Enzymol 1988; 162:551-578.
10. Song W-C, Sarrias MR, Lambris JD. Complement and innate immunity. Immunopharmacology 2000; 49:187-189.
11. Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z. Cell signals transduced by complement. Mol Immunol 2004; 41:583-597.
12. Volanakis JE, Frank MM. The human complement system in health and disease. New York: Marcel Dekker, 1998; 1-638.
13. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271:348-350.
14. Kerekes K, Prechl J, Bajtay Z, Józsi M, Erdei A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol 1998; 12:1923-1930.
15. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP. Control of the complement system. Adv Immunol 1996; 61:201-283.
16. Gorter A, Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 1999; 20:576-582.
17. Gaipl US, Kuenkele S, Voll RE, Beyer TD, Kolowos W, Heyder P, Kalden JR, Herrmann M. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 2001; 8:327-334.
18. Collard CD, Lekowski R, Jordan JE, Agah A, Stahl GL. Complement activation following oxidative stress. Mol Immunol 1999; 36:941-948.
19. Suit HD, Sedlacek RS, Silver G, Dosoretz D. Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/Sed mouse to radiation. Radiat Res 1985; 104:47-65.
20. Hara T, Matsumoto M, Tsuji S, Nagasawa S, Hiraoka A, Masaoka T, Kodama K, Horai T, Sakuma T, Seya T. Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line. Immunobiol 1996/97; 196:491-503.
21. Korbelik M. Cellular delivery and retention of Photofrin: II. The effects of human versus mouse and bovine serum. Photochem Photobiol 1992; 56:391-397.
22. Moan J, Christensen T, Jacobsen PN. Photodynamic effects on cells in vitro labeled with hematoporphyrin derivative. Photobiochem Photobiophys 1984; 7:349-358.
23. Mastellos D, Prechl J, László G, Papp K, Oláh E, Argyropoulos E, Franchini S, Tudoran R, Markiewski M, Lambris JD, Erdei A. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol 2004; 40:1213-1221.
24. Fishelson Z, Attali G, Mevorach D. Complement and apoptosis. Mol Immunol 2001; 38:207-219.
25. Prohászka Z, Singh M, Nagy K, Lakos G, Duba J, Füst G. Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones 2002; 7:17-22.
26. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 2005; 65:1018-1026.
27. Kamide R, Gigle I, Lim HW. Participation of mast cells and complement in the immediate phase of hematoporphyrin-induced phototoxicity. J Invest Dermatol 1984; 82:485-490.
28. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14:323-328.
29. Hindmarsh EJ, Marks RM. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J Immunol 1998; 160:6128-6136.
30. Korbelik M, Sun J, Zeng H. Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours. Br J Cancer 2003; 88:760-766.
31. Kilgore KS, Todd RF III, Lucchesi BR. Reperfusion injury. In: Galin JI, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlations. Philadelphia: Lippincott Williams & Wilkins 1999; 1047-1060.
32. Des Prez RM, Btyan CS, Hawiger J, Colley DG. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MGCl2-ethylene glycol tetraacetic acid. Infect Immun 1975; 11:1235-1243.
33. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188:2313-2320.
34. Mold C, Morris CA. Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation. Immunology 2001; 102:359-364.
35. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. Opsonization of apoptotic cells and its effect on macrophages and T cell immune responses. Ann N Y Acad Sci 2003; 987:68-78.
36. Erdei A, Köhler V, Schäfer H, Burger R. Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens. Immunobiol 1992; 185:314-326.